Kyungdong Pharm banner
K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 720 KRW 1.78% Market Closed
Market Cap: ₩176B

Kyungdong Pharm
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Kyungdong Pharm
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
K
Kyungdong Pharm
KOSDAQ:011040
Total Liabilities
₩74.5B
CAGR 3-Years
22%
CAGR 5-Years
15%
CAGR 10-Years
10%
Yuhan Corp
KRX:000100
Total Liabilities
₩914.1B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
6%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Liabilities
₩385.3B
CAGR 3-Years
3%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Liabilities
₩887.8B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Liabilities
₩285.2B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
15%
C
Caregen Co Ltd
KOSDAQ:214370
Total Liabilities
₩18.8B
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Kyungdong Pharm
Glance View

Market Cap
176B KRW
Industry
Pharmaceuticals

KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. The company is headquartered in Hwaseong, Gyeonggi-Do. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. The company also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Intrinsic Value
5 650.66 KRW
Overvaluation 1%
Intrinsic Value
Price ₩5 720
K

See Also

What is Kyungdong Pharm's Total Liabilities?
Total Liabilities
74.5B KRW

Based on the financial report for Sep 30, 2025, Kyungdong Pharm's Total Liabilities amounts to 74.5B KRW.

What is Kyungdong Pharm's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
10%

Over the last year, the Total Liabilities growth was 3%. The average annual Total Liabilities growth rates for Kyungdong Pharm have been 22% over the past three years , 15% over the past five years , and 10% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett